Advertisement
News
Subscribe to Pharmaceutical Processing News

The Lead

FDA Warns of Cancer Risk with Fibroid Procedure

April 18, 2014 | by MATTHEW PERRONE, AP Health Writer | Comments

The agency is discouraging doctors from performing the procedure, which uses an electronic device to grind and shred uterine tissue so it can be removed through a small incision in the abdomen. Known as laparoscopic power morcellation, the technique is widely used to treat painful fibroids, either by removing the noncancerous growths themselves or the entire uterus.

TOPICS:
View Sample

FREE Daily Email Newsletter

Cubist Pharmaceuticals Recalls One Lot of CUBICIN 500 mg in 10 mL Single Use Vials

April 18, 2014 2:45 pm | Comments

Cubist Pharmaceuticals is voluntarily recalling one lot of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles, found in a single vial from this lot, produced by a contract manufacturer.

TOPICS:

Hospira Recalls Seven Lots of Propofol Injectable Emulsion

April 18, 2014 2:36 pm | Comments

Hospira announced today that on April 2, 2014, it informed customers of a nationwide recall of seven lots of Propofol Injectable Emulsion, USP, to the user level due to a glass defect located on the interior neck of the vial, which was identified during a retain sample inspection where the glass vial contained visible embedded metal particulate. Free-floating metal particulates were also identified in vials upon further analysis

TOPICS:

NanoValent and NanoSmart to Collaborate on Cancer Treatments

April 18, 2014 8:58 am | Comments

NanoSmart and NanoValent, private pharmaceutical companies developing novel cancer pharmaceuticals, have entered into a research collaboration agreement to explore the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors.

TOPICS:
Advertisement

Late Sign-Ups Improve Outlook for Obama Health Law

April 18, 2014 8:18 am | by JOSH LEDERMAN, Associated Press; RICARDO ALONSO-ZALDIVAR, Associated Press | Comments

A surge of eleventh-hour enrollments has improved the outlook for President Barack Obama's health care law, with more people signing up overall and a much-needed spark of interest among young adults.         

TOPICS:

Actavis to Acquire Four Products from Akorn

April 18, 2014 8:12 am | Comments

Actavis has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration.The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech.

TOPICS:

Vince & Associates Clinical Research Breaks Ground on Multi-Million Dollar Expansion

April 18, 2014 7:59 am | Comments

Vince & Associates Clinical Research, a provider of comprehensive early development clinical research services for the global biopharmaceutical industry, broke ground on a new $5 million expansion of its research campus today.    

TOPICS:

FDA Approves Merck Tablet to Reduce Ragweed Allergies

April 17, 2014 4:41 pm | by The Associated Press | Comments

U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen. Ragwitek tablets dissolve quickly under the tongue. Patients are to take one daily for a few years, starting three months before ragweed season begins in late summer.

TOPICS:

AMRI Closing Syracuse-Area Lab in July

April 17, 2014 11:33 am | Comments

Albany Molecular Research Inc. announced Wednesday that it will close its 12-year-old facility in Cicero on July 15. Some employees will be transferred to Albany, Cedarburg, Wis., England and India.         

TOPICS:
Advertisement

Mylan Launches Generic ORTHO EVRA Patch

April 17, 2014 8:48 am | Comments

Mylan has launched XULANET, the generic version of Janssen Pharmaceuticals Inc.'s ORTHO EVRA (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day).              

TOPICS:

Ebola Virus in Africa Outbreak is a New Strain

April 17, 2014 8:27 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | Comments

The Ebola virus that has killed scores of people in Guinea this year is a new strain — evidence that the disease did not spread there from outbreaks in some other African nations, scientists report.         

TOPICS:

Study: Diabetic Heart Attacks and Strokes Falling

April 17, 2014 8:20 am | by MIKE STOBBE, AP Medical Writer | Comments

Over the last two decades, the rates of heart attacks and strokes among diabetics fell by more than 60 percent, a new federal study shows. The research also confirms earlier reports of drastic declines in diabetes-related kidney failure and amputations.

TOPICS:

Former NJ Drug Execs Sentenced in Stock Scheme

April 17, 2014 8:12 am | Comments

Two former pharmaceutical and medical technology firm executives have been sentenced for their involvement in an insider trading scheme.                   

TOPICS:

Servier, Lab Founder in Drug Scandal, Dies at 92

April 17, 2014 8:07 am | Comments

Jacques Servier, the founder of France's second-largest pharmaceutical group who became ensnared in a scandal over a diabetes drug widely used for weight loss, has died.              

TOPICS:

Pharmaceutical Printing Plant in Indiana to Close

April 17, 2014 8:01 am | Comments

The company that owns an Evansville, Indiana printing plant says it will be shutting it down in June and eliminating nearly 60 jobs.                    

TOPICS:

Rommelag Celebrates 50 Year Anniversary

April 16, 2014 5:06 pm | by rommelag | Comments

Fifty years ago, rommelag revolutionized plastic packaging technology with BFS.                                                     

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading